The Anti-Ageing Drugs Market is poised for growth by 2025, driven by lifestyle influences and R&D in North America and Europe.
Market Overview:
Anti-Ageing Drugs Market was valued at USD Million in 2018 and expected to reach USD Million by 2025 with a CAGR of % during the forecast period. The growing influences of lifestyle industry coupled with high levels of disposable income are some of the key factors expected to spur the growth of Global Anti-Ageing Drugs Market.
Anti-Ageing Drugs Market Key Players:
Scope of Anti-Ageing Drugs Market Report:
The global anti-ageing drugs market is set to witness huge growth potential in the coming years owing to rising awareness among the aging population regarding the use of anti-aging products. The industry however is in its infancy stage due to lot of skepticism regarding the cellular understanding of ageing process. On the other hand, the industry is also witnessing a large amount of research and development activities with drug manufacturers showing an increased focus towards significantly decreasing the impact of ageing and ultimately increasing the lifespan.
Get Sample Copy of this Premium Report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=59522&RequestType=Sample
Various recent discoveries indicating the use of pharmacology to delay and possibly improve the aging process has spurred the interest of many manufacturers. Aging is a natural process in a human life. However, such discoveries should contribute in increasing the life span of older people as well as maintain their quality of life. The introduction of such anti-ageing drugs will lead to the reduction of socio-economic burden in developed countries particularly. Citing this, research and development of anti-ageing drugs is on forefront in the developed countries of North America and Europe.
The global Anti-ageing Drugs Market is witnessing a huge surge in research activities of biotechnology companies towards development of drugs to extend normal human lifespan. For instance, Elevian, Inc. is actively conducting research focused on a protein called growth differentiating factor 11 (GDF11). This protein is found to improve brain function, exercise capacity and fasten muscle repair process when introduced in old mice.
Moreover, Elysium Health, one of the prominent players in the anti-aging market space has introduced an over the counter nutritional supplement that intends to boost one’s NAD+ levels leading to enhance longevity genes. However, clinical benefit of this supplement is not yet proven.
Increasing target population and growing influence of lifestyle industry are some of the pivotal factors boosting the market growth. The rising ageing population acts as target market for anti-ageing drugs driving the growth of this market. According to the World Health Organization (WHO), the proportion of global population over age of 60 years is predicted to double and reach 22% by 2050 from 12% in 2015. Moreover, the growing influence of lifestyle and fashion industry has led to an increased desire among the old to stay young and healthy. Apart from this, the elevating level of beauty standards has led to boost in demand for anti-ageing drugs among all age groups. Rising investments in research and development activities leading to incessant launch of new products is anticipated to be another pivotal
Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Anti-Ageing Drugs Market.
Get Methodology: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=59522&RequestType=Methodology
Anti-Ageing Drugs Market Segmentation:-
By Type:
Injectable
Oral
Topical
By Drug Class:
Antioxidants and enzymes
Serums and supplements
Stem cells
By Application:
Skin
Hair
Muscles
Age-related disorders
Others
By Region
U.S.
Canada
Mexico
UK
France
Germany
Russia
Rest of Europe
China
South Korea
India
Japan
Rest of Asia-Pacific
Latin America
Middle East
Africa
North America accounted for the largest share in Anti-Ageing Drugs Market Developed economies of U.S. and Canada are the largest revenue contributors to the global anti-ageing drugs market. This should be well justified by the high living standards, huge paying capacity and growing influence of fashion and lifestyle industry among the population. Moreover, the region houses developed infrastructure for carrying out progressive research activities aimed towards development of new anti-ageing products. These factors have collectively led to the expansion of anti-ageing drugs market in the region. Europe is set to witness similar trends as that of North America and grab the second position in the global anti-ageing drugs market. While the growing personal care industry coupled with increasing awareness regarding use of anti-ageing products in the emerging economies of China and India is expected to propel the Asia Pacific anti-ageing drugs market growth in the years to come.
Get Full Report: https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Anti-Ageing-Drugs-Market-Size/Summary
About US:
Brandessence Market Research and Consulting Pvt Ltd
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London
Contact Us:
Alan Ruffalo,
Corporate Sales: +44-2038074155
The article discusses the global trends and future scope of the Anti-Ageing Drugs Market.
Key players include Galderma, Sanofi, Allergan, and others.
Growth is driven by lifestyle influences, disposable income, and an aging population.
Explore more articles in the Research Reports category
